ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 269721 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 269721; 2) Community: the network communities that were significantly associated with the response to NSC 269721; 3) Molecule: the relationships between components within communities and NSC 269721; 4) MDR: the compounds that were significantly associated with the NSC 269721.

NSC Compound Enrichment Correlation
NSC 129794 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[m-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) 0.0385613993886001 0.29414262
NSC 135037 Jatrophone 0.0385613993886001 0.0098632955
NSC 156215 Streptovaricin complex, fraction b 0.0385613993886001 0.099136011
NSC 163424 4-Quinazolinamine, 2-[2-(1-pyrrolidinylazo)phenyl]- 0.0385613993886001 0.24778929
NSC 18805 .gamma.-Thujaplicine 0.0385613993886001 0.35884524
NSC 267713 Digitoxigenin glycoside 0.0385613993886001 0.25507062
NSC 300289 Pinafide 0.0385613993886001 0.59530118
NSC 40618 Cyclohexanone, 2,6-dibenzylidene- (8CI) 0.0385613993886001 0.075186598
NSC 45236 Null 0.0385613993886001 0.38622717
NSC 603071 Aminocamptothecin 0.0385613993886001 0.61987987
Total:61  Current:41    [First] [Prev] [Next] [Last]